Not applicableStudy completedNCT03529669What this trial is testingCytosponge™ for Post-Chemoradiation Surveillance of Oesophageal CancerWho this might be right forOesophageal Cancer University of Oxford 41
Testing effectiveness (Phase 2)Study completedNCT00607854What this trial is testingSafety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)Who this might be right forDiffuse Large B-Cell LymphomaMantle Cell Lymphoma University Hospital, Bordeaux 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06166589What this trial is testingSecond-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic CancerWho this might be right forPreviously AG Chemotherapy Treated Pancreatic Cancer Shanghai Zhongshan Hospital 19
Testing effectiveness (Phase 2)UnknownNCT04722718What this trial is testingEfficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast CancerWho this might be right forBreast Cancer Jiuda Zhao 34
Not applicableStudy completedNCT00618813What this trial is testingTwo Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of TumorsWho this might be right forEwing Sarcoma of BoneLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Children's Oncology Group 35
Not applicableUnknownNCT05573282What this trial is testingObservation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 50
Testing effectiveness (Phase 2)Study completedNCT03439280What this trial is testingInvestigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)Who this might be right forRelapsed/RefractoryMultiple Myeloma Millennium Pharmaceuticals, Inc. 50
Large-scale testing (Phase 3)UnknownNCT01872962What this trial is testingInduction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Sun Yat-sen University 480
Testing effectiveness (Phase 2)WithdrawnNCT00002761What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia Columbia University
Large-scale testing (Phase 3)Study completedNCT01661790What this trial is testingIntrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung CancerWho this might be right forMalignant Pleural Effusion Chinese PLA General Hospital 72
Not applicableStudy completedNCT04789980What this trial is testingGood Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapYWho this might be right forLocally Advanced Pancreatic CancerMetastatic Pancreatic Cancer Boryung Pharmaceutical Co., Ltd 799
Large-scale testing (Phase 3)Study completedNCT01015196What this trial is testingProspective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell TransplantationWho this might be right forAcute Myeloid Leukemia Nantes University Hospital 832
Testing effectiveness (Phase 2)Study completedNCT00045396What this trial is testingA Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS)Who this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+6 more National Cancer Institute (NCI)
Not applicableStudy completedNCT02332642What this trial is testingImmuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under ChemotherapyWho this might be right forImmuno-monitoring Universitätsmedizin Mannheim 12
Testing effectiveness (Phase 2)UnknownNCT00434369What this trial is testing5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer PatientsWho this might be right forBreast Cancer Mast Therapeutics, Inc. 31
Not applicableNot Yet RecruitingNCT06829641What this trial is testingClinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLCWho this might be right forNSCLC Stage IIIB, NSCLC Stage IIIC West China Hospital 200
Large-scale testing (Phase 3)Study completedNCT00001217What this trial is testingOsteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III StudyWho this might be right forOsteosarcoma National Cancer Institute (NCI) 260
Large-scale testing (Phase 3)Ended earlyNCT00500240What this trial is testingEffect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)Who this might be right forLeukemiaLymphoma M.D. Anderson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT03019640What this trial is testingUmbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forMantle Cell LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+4 more M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)UnknownNCT06235918What this trial is testingNeoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomasResectable Head and Neck Squamous-cell Carcinoma Xiang Lu 30